| Identification | Back Directory | [Name]
Quinoline, 2-[[4-[4-(4-pyridinyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl]phenoxy]methyl]- | [CAS]
898562-99-7 | [Synonyms]
Quinoline, 2-[[4-[4-(4-pyridinyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl]phenoxy]methyl]- | [Molecular Formula]
C26H19F3N4O | [MOL File]
898562-99-7.mol | [Molecular Weight]
460.45 |
| Chemical Properties | Back Directory | [Boiling point ]
564.4±50.0 °C(Predicted) | [density ]
1.30±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 31.25 mg/mL (67.87 mM; ultrasonic and warming and heat to 60°C) | [form ]
Solid | [pka]
4.08±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Biological Activity]
PDE10-IN-5 is a phosphodiesterase 10 (PDE 10) inhibitor, can be used for researching certain central nervous system (CNS) disorders[1]. | [storage]
Store at -20°C | [References]
[1]. Patrick Robert Verhoest, et al. Heteroaromatic quinoline compounds and their use as pde10 inhibitors. WO2006072828 A2 (Example 8) |
|
|